Illumina Nextseq 550Dx Instrument Recalled for Cybersecurity Vulnerability
Illumina is recalling 1,233 Nextseq 550Dx instruments due to a cybersecurity vulnerability that may compromise data transmission.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as Class II due to a cybersecurity vulnerability that may result in compromised data transmission. The source does not report any illnesses, injuries, or deaths.
Plain-English summary
Illumina, Inc. is recalling 1,233 units of the Nextseq 550Dx Instrument (REF: 20005715) for in vitro diagnostic use. The recall is due to a cybersecurity vulnerability identified in the communication protocol between customer-provided infrastructure and the devices, which may result in compromised data transmission.
The affected units were distributed worldwide, including nationwide in the United States and in numerous international countries. The source text does not report any illnesses, injuries, or deaths associated with this recall.
The recalled product
- Product
- Nextseq 550Dx Instrument REF: 20005715, FOR IN VITRO DIAGNOSTIC USE
- Manufacturer
- Illumina, Inc.
- Affected units
- 1,233
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots/UDI: 00816270020125
Distribution
Related recalls
Same manufacturer · Illumina, Inc.
See all →- ModerateIllumina MiSeq Dx Instrument Recalled for Cybersecurity Vulnerability
FDA (Devices) · 2026-11-11
- ModerateIllumina NovaSeq 6000Dx Instrument Recalled for Cybersecurity Vulnerability
FDA (Devices) · 2026-11-11
- ModerateIllumina VeriSeq Onsite Server V2 Recalled for Cybersecurity Vulnerability
FDA (Devices) · 2026-11-11
- ModerateIllumina DRAGEN Server Recalled for Cybersecurity Vulnerability
FDA (Devices) · 2026-11-11
- ModerateIllumina NovaSeq 6000Dx Recalled for Server Security Vulnerability
FDA (Devices) · 2026-10-07
Same hazard · cybersecurity vulnerability
See all →- ModerateIntelerad IntelePACS software recalled for cybersecurity vulnerabilities
FDA (Devices) · 2026-11-11
- ModerateNihon Kohden CNS-6200 Central Nurse Station Recalled for Cybersecurity Vulnerability
FDA (Devices) · 2026-10-14
- HighGE Healthcare Portrait Core Services Software Recall Due to Software Vulnerability
FDA (Devices) · 2026-08-12
Similar recalls
- ModerateIllumina NovaSeq 6000Dx Instrument Recalled for Cybersecurity Vulnerability
FDA (Devices) · 2026-11-11
- ModerateIllumina MiSeq Dx Instrument Recalled for Cybersecurity Vulnerability
FDA (Devices) · 2026-11-11
- HighNextSeq 550Dx sequencing instruments recalled for cybersecurity software vulnerability
FDA (Devices) · 2023-06-28
- ModerateIllumina DRAGEN Server Recalled for Cybersecurity Vulnerability
FDA (Devices) · 2026-11-11
- HighIllumina NextSeq 550 Genetic Sequencer Cybersecurity Vulnerability Recall
FDA (Devices) · 2022-06-22
- HighIllumina MiSeq Dx Sequencing Instruments Recalled Due to Cybersecurity Vulnerability
FDA (Devices) · 2022-06-22